| Organization Name | PARTEQ Innovations, Queen's University |
|---|---|
| City | Laval |
| State/Province | Quebec |
| Institutional ID Number | -- |
| Representative Name | Tony Matzouranis |
| Representative Title | Senior Director, Business Development |
| Representative Email | tmatzouranis@bellushealth.com |
| Representative Phone Number | 1-877-680-4500 |
| Technology Tags or Keywords |
BELLUS Health is a development-focused health company concentrating on the development of products that provide innovative health solutions and address critical unmet medical needs. Our vision focuses on the most important and value-creating portion of the biotech product life cycle: the one which goes from the pre-clinical stage to phase II proof-of-concept studies. Our product strategy targets both pharmaceuticals and nutraceuticals.
BELLUS Health is advancing innovative programs based on the Company's research and development of investigational product candidates to respond to serious unmet medical needs. KIACTA? (eprodisate) For the treatment of AA amyloidosis NRM8499 (prodrug of tramiprosate) For the treatment of Alzheimer's disease VIVIMIND? (homotaurine) A patented, science-based natural health product shown to protect memory function
--
